3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Respiratory Problems -

New Mayo Software Identifies and Stratifies Risk Posed by Lung Nodules

Respiratory ProblemsApr 08, 13

A multidisciplinary team of researchers at Mayo Clinic has developed a new software tool to noninvasively characterize pulmonary adenocarcinoma, a common type of cancerous nodule in the lungs. Results from a pilot study of the computer-aided nodule assessment and risk yield (CANARY) are published in the Journal of Thoracic Oncology.

“Pulmonary adenocarcinoma is the most common type of lung cancer and early detection using traditional computed tomography (CT) scans can lead to a better prognosis,” says Tobias Peikert, M.D., a Mayo Clinic pulmonologist and senior author of the study. “However, a subgroup of the detected adenocarcinomas identified by CT may grow very slowly and may be treatable with less extensive surgery.”

CANARY can noninvasively stratify the risk lung adenocarcinomas pose by characterizing the nodule as aggressive or indolent with high-sensitivity, specificity and predictive values.

CANARY uses data obtained from existing high-resolution diagnostic or screening CT images of pulmonary adenocarcinomas to match each pixel of the lung nodule to one of nine unique radiological exemplars. In testing, the CANARY classification of these lesions had an excellent correlation with the microscopic analysis of the surgically removed lesions that were examined by lung pathologists, Dr. Peikert says.

Lung cancer is the leading cause of cancer-related deaths in the United States.

“Without effective screening, most lung cancer patients present with advanced stage disease, which has been associated with poor outcomes,” Dr. Peikert says. “While CT lung cancer screening has been shown to improve patient survival, the initiation of a nationwide screening program would carry the risk of overtreatment of slow growing tumors and would be associated with substantial health care costs. CANARY represents a new tool to potentially address these issues.”

###
About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit MayoClinic.com or MayoClinic.org/news.

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.

###

Joe Dangor
507-284-5005 (days)
507-284-2511 (evenings)
.(JavaScript must be enabled to view this email address)

###
Mayo Foundation for Medical Education and Research



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Study shows treatment for genetically caused emphysema is effective
  New method enables drug target validation for COPD treatment
  Garlic extract could help cystic fibrosis patients fight infection
  New technique provides novel approach to diagnosing ciliopathies
  Innovative Experiment Aims to Boost Lung Transplants
  CPAP improves work productivity for sleep apnea patients
  Researchers explore PKC role in lung disease
  Breathing program may held save newborns’ lives: studies
  Vitamin D Improves Exercise Outcomes in Patients with COPD
  CPAP improves daytime sleepiness even in patients with low levels of symptoms
  Anti-Clotting Agent Does Not Improve Outcomes of Patients with Severe Pneumonia
  New test announced for major killer of lung transplant patients

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site